期刊文献+

改良扩大Morrow手术治疗主动脉瓣下梗阻合并左心室中部梗阻的肥厚型梗阻性心肌病中期效果分析 被引量:7

Mid-term Outcomes of Surgical Effect in 34 Patients With Hypertrophic Obstructive Cardiomyopathy Combining Mid Left Ventricular Obstruction
下载PDF
导出
摘要 目的:总结改良扩大Morrow手术(室间隔心肌切除术)治疗34例主动脉瓣下梗阻合并左心室中部梗阻的肥厚型梗阻性心肌病(HOCM)患者的中期效果。方法:纳入1996-11至2015-01在阜外医院行手术治疗的34例主动脉瓣下合并左心室中部梗阻的HOCM患者。所有患者均在全麻低温体外循环下行改良扩大Morrow手术,比较术前、术后及随访时的经胸超声心动图指标,以评估左心室中部、主动脉瓣下压差变化及心脏瓣膜功能。结果:术后平均随访时间(25.7±14.9)个月,无死亡病例,失访2例;随访时超声心动图检查显示,患者左心室中部压差[(21.0±19.8)mm Hg(1 mm Hg=0.133 k Pa)vs(60.3±29.4)mm Hg]、主动脉瓣下压差[(11.1±6.5)mm Hg vs(77.9±26.2)mm Hg]、最大室间隔厚度([17.9±7.2)mm vs(25.2±4.9)mm]、左心房直径([37.6±6.4)mm vs(41.1±7.8)mm]均较术前明显降低,左心室舒张末期内径[(42.2±4.3)mm vs(39.8±5.1)mm]较术前明显增加,差异均有统计学意义(P均<0.05);5例患者因切除范围不够导致术后左心室中部压差缓解不明显。随访时患者纽约心脏协会心功能分级明显改善(P<0.01),二尖瓣反流程度减低(P<0.01),二尖瓣收缩期前向运动现象消失。术后并发症包括:三度房室阻滞3例(8.8%),胸骨愈合不良并肺部感染二次入院1例(2.9%)。结论:改良扩大Morrow术可以减轻主动脉瓣下梗阻及左心室中部梗阻,能改善患者中期预后,有可能改善患者的左心室舒张功能。 Objective: To summarize the mid-term effect of modified extended Morrow procedure in patients with hypertrophic obstructive cardiomyopathy (HOCM) combining sub aortic valve obstruction and mid left ventricular obstruction. Methods: We studied 34 consecutive HOCM patients with sub aortic and midventricular obstruction who received modified extended Morrow procedure with extracorporeal circulation in our hospital from 1996-11 to 2015-01. Transthoracic echocardiography was conducted at pre-, post-operation and follow-up period to evaluate the changes of mid-ventricular gradient, subarctic gradient and each heart valve function. Results: The average follow-up time was (25.7± 14.9) months, 2 patients lost contact and no death occurred. In rest 32 patients, the mid ventricular gradient decreased from (60.3 ± 29.4) mmHg to (21.0 ± 19.8) mmHg, subaortic valve gradient decreased from (77.9± 26.2) mmHg to (11.6 ± 6.5) mmHg, the maximum ventricular septal thickness dropped from (25.2± 4.9) mm to (17.9± 7.2) mm, left atrial diameter reduced from (41.1 ± 7.8) mm to (37.6 ±6.4) mm, left ventricular end-diastolicdiameter increased from (39.8 ± 5.1) mm to (42.2± 4.3) mm, all P〈0.05; there were 5 patients without obviously improved mid ventricular gradient because of insufficient resection of septal myocardium in mid-ventricle. The post-operative NYHA classification was improved, P〈0.01, mitral valve regurgitation degree was decreased, P〈0.01 and SAM phenomenon was disappeared. Complications included 3 (8.8%) patients of III atrio-ventricular block, 1 (2.9%) patient of re-admission due to poorly healed sternum combining pneumonia Conclusion: Modified extended Morrow procedure may relieve sub aortic valve and mid ventricular obstruction, therefore improve left ventricular diastolic function and prognosis in relevant patients.
出处 《中国循环杂志》 CSCD 北大核心 2016年第6期578-582,共5页 Chinese Circulation Journal
关键词 心肌病 肥厚性 改良扩大Morrow术 治疗结果 Cardiomyopathy, hypertrophic Modified extended Morrow procedure Treatment outcome
  • 相关文献

参考文献21

  • 1Lopes LR, Rahman MS, Elliott PM. A systematic review and meta- analysis of genotype-phenotype associations in patients with hypertrophic eardiomyopathy caused by sarcomeric protein mutations. Heart, 2013, 99:1800-1811.
  • 2Zou Y, Song L, Wang Z, et al. Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8 080 adults. Am J Med, 2004, 116:14-18.
  • 3Smedira NG, Lytie BW, Lever HM, et al. Current effectiveness and risks of isolated septal myectomy for hypertrophic obstructive cardiomyopathy. Ann Thorac Surg, 2008, 85: 127-133.
  • 4Efthimiadis GK, Pagourelias ED, Parcharidou D, et al, Clinical characteristics and natural history of hypertrophic cardiomyopathy with midventricnlar nbslruction. Circ J, 2013, 77: 2366-2374.
  • 5Minami Y, Kajimotn K, Terajima Y, et al. Clinical implications of midventricular obstruction in patients with hypertrophic cardiomyopathy. J Am Coil Cardiol, 2011, 57: 2346-2355.
  • 6Elliott PM, Anastasakis A, Borger MA, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiornynpathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J, 2014, 35: 2733-2779.
  • 7王建德,段福建,焦盼晴,王婧金,王浩,宋云虎.经食管超声心动图在梗阻性肥厚型心肌病扩大室间隔切除术中的应用[J].中国循环杂志,2014,29(8):594-597. 被引量:7
  • 8Ommen SR, Maron B J, Olivotto I, et al. Lnng-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. J Am Coil Cardiol, 2005, 46: 470-476.
  • 9Dearani JA, Ommen SR, Gersh BJ, et al. Surgery insight: septal myectomy for obstructive hypertrophic cardiomyopathy--the Mayo Clinic experience. Nat Clin Pract Cardiovasc Med, 2007, 4: 503-512.
  • 10宋云虎,李浩杰,高歌,苏文君,然鋆,张昌伟,樊红光.行改良扩大Morrow手术治疗肥厚型梗阻性心肌病168例近中期结果[J].中国循环杂志,2014,29(5):377-381. 被引量:7

二级参考文献16

  • 1樊朝美,王雪峰,刘汉英,朱晓东.经食管超声在肥厚性梗阻型心肌病心肌切除术中的应用[J].中华超声影像学杂志,1996,5(5):230-232. 被引量:2
  • 2杨克明,宋云虎,郑哲.肥厚梗阻型心肌病的外科治疗[J].心脑血管病防治,2006,6(3):136-138. 被引量:3
  • 3Maron BJ. The 2009 international hypertrophic summit. Am J Cardiol, 2010, 105:1164-1168.
  • 4Morrow AG, Lamhrew CT, Braunwald EB. Idiopathic hypertrophic subaortic stenosis: Ⅱ. operative treatment and the resuhs of pre and postoperative hemodynamic evaluations. C i r, n l at ion, 1964, 30:120-151.
  • 5Morrow AG, Reitz BA, Epstein SE, et al. Operative treatment in hypertrophic subaortic stennsis techniques, and the resuhs of pre and postoperative assessments in 83 patients. Circulation, 1975, 52: 88-102.
  • 6Sherrid MV, Chaudhry FA, Swistel DG, et al. Obstructive hypertrophi cardiomynpathy: echocardiography, pathophysiology, and the continuing evolution of surgery for obstruction. Ann Thorac Surg, 2003, 75:620 -632.
  • 7Iacovoni A, Spirito P, Simon C, et al. A contemporary European experience with surgical septal myectomy in hypertrophic cardiomyopathy. Eur Heart J, 2012, 33: 2080-2087.
  • 8Ommen SR, Maron B J, Olivotto I, et al. Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. J Am Coil Cardiol, 2005, 46: 470-476.
  • 9Woo A, Williams WG, Choi R, et al. Clinical and echocardiographlc determinants of long-term survival after surgical myectomy in obstructive hypertrophic cardiomyopathy. Circulation, 2005, 111: 2033-2041.
  • 10Cavalcante JL, Barboza JS, Lever HM. Diversity of Mitral Valve Abnormalities in Obstructive Hypertrophic Cardiomyopathy. Prog Cardiovasc Dis, 2012, 54: 517-522.

共引文献11

同被引文献39

引证文献7

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部